C07C 279/28
Derivatives of guanidine, i.e. compounds containing the group [image cpc-sch-c07c-0970.gif], the singly-bound
Official title: having nitrogen atoms of guanidine groups bound to cyano groups, e.g. cyanoguanidines, dicyandiamides
C07C279/28 (Derivatives of guanidine, i.e. compounds containing the group [image cpc-sch-c07c-0970.gif], the singly-bound) appears on 126 US grants and 78 published applications in this corpus.
Search patents in C07C- Granted patents
- 126
- Published applications
- 78
- Assignees
- 67
- Inventors
- 243
- Latest grant
- 24 Feb 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 1 | 0 |
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 2 | 0 |
| 1981 | 4 | 0 |
| 1982 | 6 | 0 |
| 1983 | 3 | 0 |
| 1984 | 2 | 0 |
| 1985 | 5 | 0 |
| 1986 | 6 | 0 |
| 1987 | 4 | 0 |
| 1988 | 0 | 0 |
| 1989 | 5 | 0 |
| 1990 | 3 | 0 |
| 1991 | 6 | 0 |
| 1992 | 4 | 0 |
| 1993 | 0 | 0 |
| 1994 | 6 | 0 |
| 1995 | 6 | 0 |
| 1996 | 4 | 0 |
| 1997 | 2 | 0 |
| 1998 | 3 | 0 |
| 1999 | 1 | 0 |
| 2000 | 4 | 0 |
| 2001 | 3 | 1 |
| 2002 | 3 | 1 |
| 2003 | 2 | 1 |
| 2004 | 2 | 5 |
| 2005 | 3 | 3 |
| 2006 | 0 | 1 |
| 2007 | 4 | 1 |
| 2008 | 0 | 3 |
| 2009 | 0 | 0 |
| 2010 | 0 | 2 |
| 2011 | 2 | 2 |
| 2012 | 1 | 1 |
| 2013 | 1 | 0 |
| 2014 | 2 | 6 |
| 2015 | 3 | 18 |
| 2016 | 0 | 0 |
| 2017 | 1 | 10 |
| 2018 | 4 | 3 |
| 2019 | 4 | 3 |
| 2020 | 3 | 3 |
| 2021 | 1 | 2 |
| 2022 | 2 | 4 |
| 2023 | 0 | 1 |
| 2024 | 2 | 2 |
| 2025 | 3 | 2 |
| 2026 | 1 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Compositions and methods for treatment24 Feb 2026US 12,558,350 B2Bausch + Lomb Ireland Limited
- Compounds and compositions for intracellular delivery of therapeutic agents2 Sep 2025US 12,404,232 B2ModernaTX, Inc.
- Compounds and compositions for intracellular delivery of therapeutic agents10 Jun 2025US 12,324,859 B2ModernaTX, Inc.
- Compounds and compositions for intracellular delivery of therapeutic agents1 Apr 2025US 12,263,248 B2ModernaTX, Inc.
- Compounds and compositions for intracellular delivery of therapeutic agents26 Nov 2024US 12,151,995 B2ModernaTX, Inc.
- N-(benzhydryl)cycloalkylcarboxamide derivatives as inhibitors of glycogen synthase 1 (gys1) and methods of use thereof26 Mar 2026US 2026/0085034 A1Maze Therapeutics, Inc.
- Compounds and compositions for intracellular delivery of therapeutic agents19 Mar 2026US 2026/0078082 A1ModernaTX, Inc.
- Compounds and compositions for intracellular delivery of therapeutic agents12 Mar 2026US 2026/0069549 A1ModernaTX, Inc.
- Compounds and compositions for intracellular delivery of therapeutic agents17 Jul 2025US 2025/0228777 A1ModernaTX, Inc.
- Epoxy resin compositions comprising dicyandiamid curing agent8 May 2025US 2025/0145760 A13M Innovative Properties Company
Most cited
By later US patents
- Compounds and compositions for intracellular delivery of therapeutic agents143US 9,868,691 B2ModernaTX, Inc. · 2018
- Compounds and compositions for intracellular delivery of therapeutic agents88US 10,857,105 B2MordernaTX, Inc. · 2020
- Compositions and methods for treatment of eye disorders84US 8,168,655 B2Sarcode Bioscience Inc. · 2012
- Meta-substituted phenylene derivatives72US 5,773,646 AG. D. Searle & Co. · 1998
- Compounds and compositions for intracellular delivery of therapeutic agents62US 9,868,692 B2ModernaTX, Inc. · 2018